2017
DOI: 10.12669/pjms.335.12830
|View full text |Cite
|
Sign up to set email alerts
|

Clinical effects of Ganglioside and fructose-1, 6-diphosphate on neonatal heart and brain injuries after Asphyxia

Abstract: Objective:To study the clinical effect of ganglioside (GM) and fructose-1, 6-diphosphate (FDP) on neonatal heart and brain injuries after asphyxia.Methods:Ninety-one neonates with asphyxia neonatal heart and brain injuries were randomly divided into an observation group and a control group. Both groups were given symptomatic treatment as soon as possible. On this basis, the observation group was given 200 mL of 5% glucose injection and 20 mg of GM and 250 mg/kg·d FDP by intravenous infusion. The above two drug… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Zhu et al (11) stated that levels of CK-MB began to rise within the first few hours of life and were significantly higher in moderate and severe grades of neonatal hypoxia ischemia compared with mild grades and normal controls within the first 2-4 h. Levels of CKMB in asphyxiated infants rose to a significant peak at 12 h of life before returning to a low level at 48 h of life. There was no significant difference in the serial serum CKMB levels during the first 48 h of life between asphyxiated infants with and without hypotension, between infants who had normal or abnormal ECGs, between infants with and without heart failure, between infants with low and normal EF or between infants who survived or died.…”
Section: Discussionmentioning
confidence: 99%
“…Zhu et al (11) stated that levels of CK-MB began to rise within the first few hours of life and were significantly higher in moderate and severe grades of neonatal hypoxia ischemia compared with mild grades and normal controls within the first 2-4 h. Levels of CKMB in asphyxiated infants rose to a significant peak at 12 h of life before returning to a low level at 48 h of life. There was no significant difference in the serial serum CKMB levels during the first 48 h of life between asphyxiated infants with and without hypotension, between infants who had normal or abnormal ECGs, between infants with and without heart failure, between infants with low and normal EF or between infants who survived or died.…”
Section: Discussionmentioning
confidence: 99%